InsidersTradesSigma
Total declarations
Companies
▲ Purchases (34 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
34
Disclosed sells
1
T+90 hit rate
20%
T+90 mean return
-17.5%
Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by BROWN JEFFREY J, Director. Director active across 3 companies, notably MEDIFAST INC. In total, 44 reports have been recorded. Breakdown: 34 buys · 1 sell. Total volume traded: €4.4m. History available since 6 May 2021. The latest transaction was filed on 6 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations44 total
21,730 shares@ US$23.7564.6% of flowCOMMON STOCKSEC:0000933036-25-000108:0
Ideal exit: 31 Jan 2026 (T+270)
1,694 shares@ US$19.894.2% of flowCOMMON STOCKSEC:0000933036-25-000081:0
Ideal exit: 17 Jan 2026 (T+270)
1,146 shares@ US$29.014.5% of flowCOMMON STOCKSEC:0000933036-25-000024:0
Ideal exit: 4 Oct 2025 (T+270)
1,065 shares@ US$29.254.1% of flowCOMMON STOCKSEC:0000933036-24-000171:0
Ideal exit: 19 Jul 2025 (T+270)
1,031 shares@ US$29.824.0% of flowCOMMON STOCKSEC:0000933036-24-000122:0
Ideal exit: 5 Apr 2025 (T+270)
6,596 shares0Common StockSEC:0001628280-24-029661:0
991 shares@ US$30.684.1% of flowCOMMON STOCKSEC:0000933036-24-000086:0
Ideal exit: 17 Jan 2025 (T+270)
912 shares@ US$32.943.9% of flowCOMMON STOCKSEC:0000933036-24-000022:0
Ideal exit: 5 Oct 2024 (T+270)
96.736 shares@ US$70.550.4% of flowCommon StockSEC:0001628280-23-038375:0
Ideal exit: 30 Jul 2024 (T+270)
988 shares@ US$27.613.7% of flowCOMMON STOCKSEC:0000933036-23-000168:0
Ideal exit: 20 Jul 2024 (T+270)
15,154 shares@ US$92.6075.7% of flowCommon StockSEC:0001628280-23-029696:0
621.765 shares@ US$100.033.3% of flowCommon StockSEC:0001628280-23-028943:0
Ideal exit: 30 Apr 2024 (T+270)
877 shares@ US$30.783.5% of flowCOMMON STOCKSEC:0000933036-23-000126:0
Ideal exit: 6 Apr 2024 (T+270)
3,289 shares0Common StockSEC:0001628280-23-022795:0
680.53 shares@ US$89.743.3% of flowCommon StockSEC:0001628280-23-017667:0
Ideal exit: 30 Jan 2024 (T+270)
1,143 shares@ US$23.283.4% of flowCOMMON STOCKSEC:0000933036-23-000084:0
Ideal exit: 19 Jan 2024 (T+270)
11.211 shares@ US$114.970.1% of flowCommon StockSEC:0001628280-23-003054:0
Ideal exit: 4 Nov 2023 (T+270)
1,084 shares@ US$24.201.2% of flowCOMMON STOCKSEC:0000933036-23-000021:0
Ideal exit: 7 Oct 2023 (T+270)
11.872 shares@ US$106.930.1% of flowCommon StockSEC:0001628280-22-029564:0
Ideal exit: 5 Aug 2023 (T+270)
1,475 shares@ US$17.451.3% of flowCOMMON STOCKSEC:0000933036-22-000168:0
Ideal exit: 22 Jul 2023 (T+270)
410 shares@ US$125.723.0% of flowCommon StockSEC:0001104659-22-089416:0
Ideal exit: 6 May 2023 (T+270)
9.04 shares@ US$138.780.1% of flowCommon StockSEC:0001104659-22-088736:0
1,223 shares@ US$20.691.2% of flowCOMMON STOCKSEC:0000933036-22-000131:0
Ideal exit: 8 Apr 2023 (T+270)
1,580 shares0Common StockSEC:0001104659-22-073169:0
315.236 shares@ US$183.250.039% mcap22.8% of flowCommon StockSEC:0001104659-22-058940:0
Ideal exit: 30 Jan 2023 (T+270)
25 of 44 declarations
About BROWN JEFFREY J
Jeffrey J. Brown is an executive at Medifast Inc.
